CTT Pharmaceutical Holdings, Inc.
CTTH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001035422
In the last 90 days, CTT Pharmaceutical Holdings, Inc. insiders filed 14 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 12:11 PM ET
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|
| Period end | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
| Filing | 10-K/A | 10-K | 10-K | 10-K |
| Reported | – | – | – | – |
| Operating expenses | $672.2K | -$92.2K | $1.19M | $757.9K |
| Selling, general and administrative | $17.6K | -$160.4K | $158.4K | $316.4K |
| Operating income | -$672.2K | $92.2K | -$1.19M | -$757.9K |
| Net income | -$672.2K | $110.5K | -$1.00M | $3.74M |
| EPS, basic | – | $0.01 | $-0.11 | $0.42 |
| EPS, diluted | – | $0.01 | $-0.11 | $0.40 |
| Weighted shares, basic | – | 9.41M | 9.41M | 8.92M |
| Weighted shares, diluted | – | 9.41M | 9.41M | 9.49M |
| Margins and growth | ||||
| Net income growth, year over year | −708.5% | – | −126.8% | – |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|
| Period end | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
| Filing | 10-K/A | 10-K | 10-K | 10-K |
| Reported | – | – | – | – |
| Cash and equivalents | $81.2K | $823 | $12.1K | $569.4K |
| Short-term investments | – | $0 | $164.3K | – |
| Accounts receivable | $5.43K | $5.43K | $8.72K | $151 |
| Total current assets | $1.05M | $6.25K | $203.1K | $750.7K |
| Property, plant and equipment | – | – | – | $0 |
| Total assets | $1.66M | $6.25K | $203.1K | $4.18M |
| Total current liabilities | – | $249.4K | $589.4K | $3.73M |
| Total liabilities | $169.5K | $249.4K | $589.4K | $3.73M |
| Shareholders' equity | $1.49M | -$243.1K | -$386.3K | $456.4K |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|
| Period end | Dec 31, 2014 | Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 |
| Filing | 10-K/A | 10-K | 10-K | 10-K |
| Reported | – | – | – | – |
| Operating cash flow | -$72.3K | -$136.2K | -$1.03M | -$316.1K |
| Depreciation and amortization | – | – | – | $0 |
| Stock-based compensation | $308.4K | $0 | $42.3K | $155.4K |
| Investing cash flow | $151.9K | $125.0K | $436.0K | $877.0K |
| Financing cash flow | – | $0 | $33.8K | -$37.7K |
| Net change in cash | $81.2K | -$11.3K | -$557.3K | $523.2K |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
| Cover date | Shares outstanding | Change in a year | Filing |
|---|---|---|---|
| Sep 11, 2026 | 59.7M | – | SEC |
| Nov 15, 2015 | 21.3M | −88.4% | SEC |
| Nov 10, 2015 | 21.3M | −88.4% | SEC |
| Nov 4, 2015 | 21.3M | −88.4% | SEC |
| Sep 30, 2015 | 21.3M | −88.4% | SEC |
| Aug 14, 2015 | 195.1M | +454.4% | SEC |
| May 15, 2015 | 195.1M | +1,974.9% | SEC |
| Apr 6, 2015 | 195.1M | +1,974.9% | SEC |
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.